{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:23:16Z","timestamp":1761988996260},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jvir.2016.05.037","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T09:17:29Z","timestamp":1470907049000},"page":"1494-1501","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Influence of Statin Therapy on Restenosis in Patients Who Underwent Nitinol Stent Implantation for de Novo Femoropopliteal Artery Disease: Two-Year Follow-up at a Single Center"],"prefix":"10.1016","volume":"27","author":[{"given":"Wonho","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ripal T.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantino S.","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul E.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie B.","family":"Schernthaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan M.","family":"Acu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor N.","family":"Becerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry T.","family":"Katzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2016.05.037_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.tvir.2004.01.007","article-title":"Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results","volume":"7","author":"Mewissen","year":"2004","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2016.05.037_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1024\/0301-1526\/a000440","article-title":"Restenosis after endovascular revascularization in peripheral artery disease","volume":"44","author":"Malyar","year":"2015","journal-title":"Vasa"},{"key":"10.1016\/j.jvir.2016.05.037_bib3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jvs.2012.06.053","article-title":"Lower extremity bypass vs endovascular therapy for young patients with symptomatic peripheral arterial disease","volume":"56","author":"Lep\u00e4ntalo","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvir.2016.05.037_bib4","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2006.07.031","article-title":"Long-term results after directional atherectomy of femoro-popliteal lesions","volume":"48","author":"Zeller","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvir.2016.05.037_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jvir.2016.05.037_bib6","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jacc.2007.11.072","article-title":"Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study","volume":"51","author":"Shepherd","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvir.2016.05.037_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0005-2760(96)00184-1","article-title":"Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types","volume":"1345","author":"Negre-Aminou","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jvir.2016.05.037_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s003950200000","article-title":"Pleiotropic effects of HMG-CoA reductase inhibitors","volume":"97","author":"Werner","year":"2002","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jvir.2016.05.037_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00005344-200004000-00016","article-title":"Effects of cerivastatin on human arterial smooth muscle cell proliferation and migration in transfilter cocultures","volume":"35","author":"Axel","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jvir.2016.05.037_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2006.06.012","article-title":"Statins and the endothelium","volume":"46","author":"Ii","year":"2007","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jvir.2016.05.037_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1526602815592206","article-title":"An update on methods for revascularization and expansion of the tasc lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"22","author":"Jaff","year":"2015","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvir.2016.05.037_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0301-5629(92)90082-L","article-title":"Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction","volume":"18","author":"Ranke","year":"1992","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jvir.2016.05.037_bib13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"25 Suppl 2","key":"10.1016\/j.jvir.2016.05.037_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jvir.2016.05.037_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jacc.2011.09.037","article-title":"The treatment of femoropopliteal in-stent restenosis: back to the future","volume":"59","author":"Laird","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvir.2016.05.037_bib16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2169\/internalmedicine.45.1757","article-title":"Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction","volume":"45","author":"Iwata","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.jvir.2016.05.037_bib17","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/S0735-1097(01)01662-X","article-title":"Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation","volume":"38","author":"Walter","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvir.2016.05.037_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjcard.2005.07.107","article-title":"Effects of morning versus evening intake of atorvastatin on major cardiac event and restenosis rates in patients undergoing first elective percutaneous coronary intervention","volume":"97","author":"Ozaydin","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvir.2016.05.037_bib19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0735-1097(98)00514-2","article-title":"Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions","volume":"33","author":"Kaesemeyer","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvir.2016.05.037_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MCA.0b013e32832c4538","article-title":"Intensive lowering of blood pressure and low-density lipoprotein cholesterol with statin therapy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease","volume":"20","author":"Takamiya","year":"2009","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jvir.2016.05.037_bib21","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jvir.2016.05.037_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.atherosclerosis.2011.04.005","article-title":"The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline","volume":"218","author":"West","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvir.2016.05.037_bib23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0002-9149(00)01079-1","article-title":"Effect of simvastatin on restenosis after percutaneous transluminal angioplasty of femoropopliteal arterial obstruction","volume":"86","author":"Hagenaars","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvir.2016.05.037_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF02577644","article-title":"Neointimal hyperplasia in low-profile Nitinol stents, Palmaz stents, and Wallstents: a comparative experimental study","volume":"19","author":"Sch\u00fcrmann","year":"1996","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2016.05.037_bib25","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the reach registry","volume":"35","author":"Kumbhani","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvir.2016.05.037_bib26","doi-asserted-by":"crossref","first-page":"e000697","DOI":"10.1161\/JAHA.113.000697","article-title":"Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease","volume":"3","author":"Armstrong","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jvir.2016.05.037_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jacc.2008.09.020","article-title":"Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication","volume":"53","author":"Soga","year":"2009","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044316302408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044316302408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T08:58:53Z","timestamp":1536483533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044316302408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1051044316302408"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2016.05.037","relation":{},"ISSN":["1051-0443"],"issn-type":[{"type":"print","value":"1051-0443"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Influence of Statin Therapy on Restenosis in Patients Who Underwent Nitinol Stent Implantation for de Novo Femoropopliteal Artery Disease: Two-Year Follow-up at a Single Center","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2016.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2016.","name":"copyright","label":"Copyright"}]}}